Target intelligence / Profile preview

CCNY antisense RNA 1 (CCNY-AS1)

Target
CCNY-AS1
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

CCNY antisense RNA 1 (CCNY-AS1) is a long non-coding RNA transcribed from the antisense strand relative to the coding *CCNY* gene (Cyclin Y). As an antisense RNA, it may regulate *CCNY* expression or contribute to gene regulatory networks that impact cellular processes, but currently no direct biological function, disease role, or drug interaction is established for CCNY-AS1, and it is not considered a therapeutic target. Most published research on antisense RNAs indicates they frequently modulate target gene expression or chromatin states, mainly through transcriptional or epigenetic mechanisms, but no such specific evidence for CCNY-AS1 itself is present in current curated literature[2][3]. There is no indication of a misspelling or major error regarding CCNY-AS1; AL117336.3 is a valid alternative identifier for the same transcript. No specific functional classification such as "receptor," "enzyme," or "transporter" applies to CCNY-AS1, since it is a non-coding regulatory RNA. There are no reported drugs, mechanisms, biomarker utilities, or safety concerns directly associated with CCNY-AS1. This target should be considered a member of the long non-coding RNA family and *antisense RNA* sub-category, with a putative biological role in gene regulation (by analogy to other antisense lncRNAs), but lacking direct therapeutic relevance or actionable evidence[2][3].

Other names
CCNY-AS1AL117336.3
02

Biological functions

Potential regulation of *CCNY* gene transcription (inference based on antisense RNA general functions[2])Other
03

Disease associations

Other (no specific disease involvement documented)

Beyond the preview

Go deeper on CCNY antisense RNA 1 (CCNY-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCNY antisense RNA 1 (CCNY-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call